CASTAGNA, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 3.590
EU - Europa 2.781
AS - Asia 872
SA - Sud America 14
AF - Africa 7
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.271
Nazione #
US - Stati Uniti d'America 3.580
GB - Regno Unito 976
CN - Cina 782
SE - Svezia 342
DE - Germania 328
FR - Francia 267
IE - Irlanda 255
IT - Italia 254
FI - Finlandia 187
UA - Ucraina 66
BE - Belgio 40
VN - Vietnam 36
RU - Federazione Russa 21
IN - India 13
TR - Turchia 13
NL - Olanda 12
CA - Canada 10
CL - Cile 9
IR - Iran 7
AU - Australia 6
EE - Estonia 4
EG - Egitto 4
HK - Hong Kong 4
IL - Israele 4
ES - Italia 3
HU - Ungheria 3
PK - Pakistan 3
CH - Svizzera 2
GR - Grecia 2
HR - Croazia 2
JP - Giappone 2
KG - Kirghizistan 2
KR - Corea 2
LV - Lettonia 2
NO - Norvegia 2
PL - Polonia 2
PT - Portogallo 2
SG - Singapore 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EU - Europa 1
IS - Islanda 1
KE - Kenya 1
MD - Moldavia 1
MU - Mauritius 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 7.271
Città #
Southend 857
Chandler 747
Jacksonville 505
Ann Arbor 359
Woodbridge 308
Dublin 255
Houston 203
Ashburn 154
Beijing 139
New York 130
Wilmington 120
Verona 104
Lawrence 103
Princeton 103
Jinan 81
Nanjing 75
Shenyang 69
Helsinki 50
Hebei 42
Redmond 42
Brussels 40
Sindelfingen 35
Lancaster 33
Tianjin 30
Zhengzhou 30
Changsha 29
Haikou 29
Nanchang 29
Jiaxing 24
Dong Ket 20
Hangzhou 20
Milan 20
Seattle 20
Taiyuan 20
Boardman 19
Taizhou 17
Ningbo 16
Falls Church 15
Guangzhou 15
Norwalk 15
Nürnberg 14
Fuzhou 13
Fairfield 12
Boydton 11
Dearborn 11
Redwood City 11
Washington 10
Bologna 9
Düsseldorf 9
Lanzhou 9
San Mateo 7
Toronto 7
Auburn Hills 6
San Francisco 6
Trento 6
Ardabil 5
Clearwater 5
Meppel 5
Bussolengo 4
Catanzaro 4
Hong Kong 4
Las Vegas 4
Ospedaletto Euganeo 4
Riva 4
San Giovanni Lupatoto 4
Shanghai 4
Bangalore 3
Borgo Valsugana 3
Budapest 3
Cambridge 3
Canberra 3
Fermo 3
Groningen 3
Kharkov 3
Kochi 3
London 3
Madison 3
Montréal 3
San Diego 3
Tallinn 3
Tappahannock 3
Tomsk 3
Berlin 2
Bishkek 2
Boston 2
Brescia 2
Cairo 2
Chicago 2
Cupertino 2
Dongguan 2
Frankfurt am Main 2
Getxo 2
Hefei 2
Isola Vicentina 2
Menlo Park 2
Monmouth Junction 2
Montelupone 2
Münster 2
Nagold 2
Randolph 2
Totale 5.194
Nome #
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 226
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 118
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study. 116
The proteome: anno Domini 2002 110
Tarrgeted Exome Sequencing of 5 Hemochromatosis Genes in Iron Overloaded Patients by Next Generation Sequencing (NGS) Platform. 99
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 98
Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study. 97
Apolipoprotein -CIII glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 96
Immunoaffinity reactors for prion protein qualitative analysis 93
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 93
“Critical survey of quantitative proteomics in two-dimensional electrophoretic approaches” 91
miRNAs purification and analysis from urinary exosomes. 90
Comparative two-dimensional mapping of prion protein isoforms in human cerebrospinal fluid and central nervous system 88
“Proteome analysis in the clinical chemistry laboratory: myth or reality?” 88
Identification of new BMP6 pro-peptide mutations in patients with iron overload 88
ApoCIII glycoforms determination and proteomic analysis in plasma of coronary patients with different ApoCIII levels . 88
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 87
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 87
HEPCIDIN REPRESSION BY PROMOTER DNA HYPERMETHYLATION IN NON-VIRAL HEPATOCELLULAR CARCINOMA 87
"Exploring the hidden human urinary proteome via ligand library beads" 86
Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin 86
pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease 86
Isoelectric beads for proteome pre-fractionation.II :experimental evaluation in a multicompartment electroyzer 85
Hepcidin Inhibition by Modified Heparins without Anticoagulant Activity 85
Altered paraoxonase expression in patients with genetic haemochromatosis. 84
Hepcidin and DNA promoter methylation in hepatocellular carcinoma 84
Monocyte/macrophage proteomics: recent findings and biomedical applications. 82
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 82
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 81
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 80
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 80
Altered iron parameters and hepcidin levels in a general population: lesson from the CHRIS study 80
“Proteomics approaches for studying chemoresistance in cancer” 79
Murine macrophages response to iron 79
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 79
“Conventional isoelectric focusing in gel slabs and capillaries and immobilized pH gradients” 78
Clinical, pathological, and molecular correlates in ferroportin disease: a study of two novel mutations. 78
Amphoteric,buffering chromatographic beads for proteome prefractionation.I :theoretical model 77
How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques 77
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 76
Iron metabolism in Murine Macrophages: a proteomic insight. 76
Plasma proteomic analysis of patients with Coronary Artery Disease with different levels of apolipoprotein CIII 76
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 74
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 73
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 73
Prefractionation techniques in proteome analysis: the mining tools of the third millennium. 72
Reduced serum hepcidin levels in patients with chronic hepatitis C 71
Apolipoprotein C-III glycoforms correlate heterogeneously with plasma lipid profile in subjects with coronary artery disease 71
Surface plasmon resonance based on molecularly imprinted nanoparticles for the picomolar detection of the iron regulating hormone Hepcidin-25 70
Myristic acid plasma levels are strongly correlated with triglyceride and Apolipoprotein C-III plasma concentration in a cohort of subjects with or without coronary artery disease 70
A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. 69
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 69
Carbamylation of proteins in 2-D electrophoresis--myth or reality? 68
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis. 68
High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics 68
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 68
Increased plasma thrombin potential is associated with stable coronary artery disease: An angiographically-controlled study 67
Aceruloplasminemia: A Severe Neurodegenerative Disorder Deserving an Early Diagnosis 67
Beta-elimination: an unexpected artefact in proteome analysis. 66
Prefractionation techniques in proteome analysis. 66
Imprinted polymers for the recognition/quantitation of the peptide hormone hepcidin 66
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 66
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 66
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 63
Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome 63
Prefractionation techniques in proteome analysis. 62
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 62
Reducing protein concentration range of biological samples using solid-phase ligand libraries 61
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism 61
The role of TMPRSS6 and HFE variants in iron deficiency anemia in celiac disease 60
Myristic acid induces proteomic and secretomic changes associated with steatosis, cytoskeleton remodeling, endoplasmic reticulum stress, protein turnover and exosome release in HepG2 cells 60
Optimizing the purification and analysis of miRNAs from urinary exosomes. 59
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material 59
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 59
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis 58
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy 58
"Prefractionation of urinary proteins" 56
”SPR biosensors and “natural hepcidin receptor” immobilization for hepcidin-25 determination in serum.” 56
Hepcidin assay in serum by SELDI-TOF-MS and other approaches 54
Hormone-Dependent Changes in Female Urinary Proteome 54
Hepcidin resistance in dysmetabolic iron overload 53
Modern iron replacement therapy: clinical and pathophysiological insights 52
Measurament of urinary hepcidin levels by self-tof-ms in HFE-hemochromatosis 51
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. 50
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 50
Plasma Proteome Profiles of Stable CAD Patients Stratified According to Total Apo C-III Levels 49
Recent trends in proteome analysis. 48
Urinary Metabolic Signature of Primary Aldosteronism: Gender and Subtype-Specific Alterations 47
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 46
null 44
A Novel ALAS2 Missense Mutation in Two Brothers With Iron Overload and Associated Alterations in Serum Hepcidin/Erythroferrone Levels 44
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 44
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 43
Sucrosomial® Iron Supplementation in Mice: Effects on Blood Parameters, Hepcidin, and Inflammation 43
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 43
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 43
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 40
Impact of natural Neuromedin-B receptor variants on iron metabolism 39
Treatment options for anemia in the elderly 35
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 35
Totale 7.148
Categoria #
all - tutte 23.174
article - articoli 17.683
book - libri 0
conference - conferenze 4.896
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 595
Totale 46.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201967 0 0 0 0 0 0 0 0 0 17 24 26
2019/2020897 116 11 7 70 103 107 116 67 57 110 41 92
2020/2021848 61 122 64 113 112 89 25 53 45 25 91 48
2021/2022819 62 259 8 64 25 25 7 37 43 19 76 194
2022/20232.045 121 234 168 338 201 477 31 128 264 13 36 34
2023/2024759 43 88 74 108 120 210 21 70 12 13 0 0
Totale 7.393